Legal & General Group’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8K Sell
1,498
-82
-5% -$1.43K ﹤0.01% 2904
2025
Q4
$28.1K Sell
1,580
-11,914
-88% -$209K ﹤0.01% 2898
2025
Q3
$250K Sell
13,494
-2,218
-14% -$45.7K ﹤0.01% 2571
2025
Q2
$337K Buy
15,712
+82
+0.5% +$1.77K ﹤0.01% 2540
2025
Q1
$385K Sell
15,630
-1,312
-8% -$32.4K ﹤0.01% 2483
2024
Q4
$393K Hold
16,942
﹤0.01% 2543
2024
Q3
$459K Buy
16,942
+127
+0.8% +$3.85K ﹤0.01% 2492
2024
Q2
$484K Buy
16,815
+1,468
+10% +$45K ﹤0.01% 2429
2024
Q1
$448K Hold
15,347
﹤0.01% 2471
2023
Q4
$499K Sell
15,347
-52
-0.3% -$1.51K ﹤0.01% 2448
2023
Q3
$493K Sell
15,399
-108
-0.7% -$4.16K ﹤0.01% 2447
2023
Q2
$680K Buy
15,507
+8,699
+128% +$401K ﹤0.01% 2355
2023
Q1
$302K Buy
6,808
+1,327
+24% +$58.7K ﹤0.01% 2449
2022
Q4
$218K Buy
5,481
+79
+1% +$3.29K ﹤0.01% 2580
2022
Q3
$249K Buy
5,402
+524
+11% +$25.7K ﹤0.01% 2544
2022
Q2
$210K Buy
4,878
+233
+5% +$10.7K ﹤0.01% 2611
2022
Q1
$251K Sell
4,645
-7
-0.2% -$358 ﹤0.01% 2595
2021
Q4
$279K Buy
4,652
+30
+0.6% +$1.87K ﹤0.01% 2587
2021
Q3
$302K Buy
4,622
+2,684
+138% +$174K ﹤0.01% 2567
2021
Q2
$122K Hold
1,938
﹤0.01% 2672
2021
Q1
$95K Sell
1,938
-99
-5% -$4.75K ﹤0.01% 2637
2020
Q4
$84K Hold
2,037
﹤0.01% 2634
2020
Q3
$93K Sell
2,037
-402
-16% -$18.6K ﹤0.01% 2510
2020
Q2
$106K Sell
2,439
-78
-3% -$3.51K ﹤0.01% 2509
2020
Q1
$100K Sell
2,517
-280
-10% -$12.6K ﹤0.01% 2411
2019
Q4
$132K Buy
2,797
+1,249
+81% +$48.4K ﹤0.01% 2510
2019
Q3
$55K Hold
1,548
﹤0.01% 2707
2019
Q2
$60K Buy
1,548
+206
+15% +$8.31K ﹤0.01% 2699
2019
Q1
$59K Buy
1,342
+197
+17% +$7.49K ﹤0.01% 2651
2018
Q4
$40K Hold
1,145
﹤0.01% 2775
2018
Q3
$42K Hold
1,145
﹤0.01% 2862
2018
Q2
$31K Buy
1,145
+346
+43% +$7.38K ﹤0.01% 3001
2018
Q1
$12K Hold
799
﹤0.01% 3195
2017
Q4
$15K Buy
+799
New +$15.3K ﹤0.01% 3192

Other funds holding KIDS

Legal & General Group's KIDS Position: Q1 2026 in Review

Legal & General Group reduced its OrthoPediatrics (KIDS) stake by 5.2% in Q1 2026, selling an estimated $1.43K and leaving 1,498 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2904.

Legal & General Group first reported a position in KIDS in Q4 2017 and has held it in 34 quarters since. The position peaked at $680K in Q2 2023. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Legal & General Group held 1,498 shares of OrthoPediatrics worth $23.8K as of Q1 2026.
  • Legal & General Group sold 82 OrthoPediatrics shares in Q1 2026, an estimated $1.43K.
  • OrthoPediatrics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2904 holding.
  • Legal & General Group first reported a position in OrthoPediatrics in Q4 2017 and has held it in 34 quarters since.
  • Legal & General Group's OrthoPediatrics position peaked at $680K in Q2 2023.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.